FM-VP4 for the treatment of hyperlipidemia
April 2, 2004 by admin · Leave a Comment
On April 5, 2004 Forbes Medi-Tech Inc. announced preliminary results of its Phase II clinical trial of FM-VP4 for the treatment of hyperlipidemia. The company reported that statistical significance was achieved at the trial’s primary endpoint of lowering low density lipoprotein (LDL) cholesterol. An 11% reduction in LDL cholesterol, as compared to placebo, was reported [...]
Surveillance Summary Mar 27 – Apr 2, 2004
April 2, 2004 by admin · Leave a Comment
The Biohorizon emerging health technology surveillance system experienced moderate to heavy activity throughout Week 14 of 2004 with a total of 23 updated technologies. Of these, 2 were new detects while 21 were already present in the Biohorizon database. The average impact score was 42, up two from last week. A broad spectrum of target [...]